Your browser doesn't support javascript.
loading
Phosphoprotein-based biomarkers as predictors for cancer therapy.
Carter, Angela M; Tan, Chunfeng; Pozo, Karine; Telange, Rahul; Molinaro, Roberto; Guo, Ailan; De Rosa, Enrica; Martinez, Jonathan O; Zhang, Shanrong; Kumar, Nilesh; Takahashi, Masaya; Wiederhold, Thorsten; Ghayee, Hans K; Oltmann, Sarah C; Pacak, Karel; Woltering, Eugene A; Hatanpaa, Kimmo J; Nwariaku, Fiemu E; Grubbs, Elizabeth G; Gill, Anthony J; Robinson, Bruce; Gillardon, Frank; Reddy, Sushanth; Jaskula-Sztul, Renata; Mobley, James A; Mukhtar, M Shahid; Tasciotti, Ennio; Chen, Herbert; Bibb, James A.
Afiliación
  • Carter AM; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233.
  • Tan C; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Pozo K; Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Telange R; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Molinaro R; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233.
  • Guo A; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX 77030.
  • De Rosa E; Department of Biomolecular Sciences, University of Urbino Carlo Bo, 61029, Urbino, Italy.
  • Martinez JO; Bluefin Biomedicine, Beverly, MA 01915.
  • Zhang S; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX 77030.
  • Kumar N; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030.
  • Takahashi M; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX 77030.
  • Wiederhold T; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Ghayee HK; Department of Biology, University of Alabama at Birmingham, Birmingham, AL 35233.
  • Oltmann SC; Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Pacak K; Cell Signaling Technology, Danvers, MA 01923.
  • Woltering EA; Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, FL 32608.
  • Hatanpaa KJ; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Nwariaku FE; Harrold B. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Grubbs EG; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
  • Gill AJ; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA 70112.
  • Robinson B; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Gillardon F; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Reddy S; Harrold B. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
  • Jaskula-Sztul R; Department of Surgical Oncology, University of Texas MD Anderson Medical Center, Houston, TX 77030.
  • Mobley JA; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, University of Sydney, 2065 St Leonards, Australia.
  • Mukhtar MS; Kolling Institute and Department of Endocrinology, Royal North Shore Hospital, University of Sydney, 2065 St Leonards, Australia.
  • Tasciotti E; Central Nervous System (CNS) Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.
  • Chen H; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233.
  • Bibb JA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35233.
Proc Natl Acad Sci U S A ; 117(31): 18401-18411, 2020 08 04.
Article en En | MEDLINE | ID: mdl-32690709

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Tumores Neuroectodérmicos / Inhibidores de Proteínas Quinasas / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfoproteínas / Tumores Neuroectodérmicos / Inhibidores de Proteínas Quinasas / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article